Quadrature Capital’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-87,060
Closed -$234K 1627
2026
Q1
$234K Buy
87,060
+20,683
+31% +$57.4K ﹤0.01% 1063
2025
Q4
$145K Buy
66,377
+23,465
+55% +$58.1K ﹤0.01% 1035
2025
Q3
$100K Buy
+42,912
New +$73.6K ﹤0.01% 875

Other funds holding CABA

Quadrature Capital's CABA Position: Q2 2026 in Review

Quadrature Capital sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 87,060 shares — an estimated $234K sold.

Quadrature Capital first reported a position in CABA in Q3 2025 and held it in 3 quarters. The position peaked at $234K in Q1 2026. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Quadrature Capital reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 87,060 Cabaletta Bio shares in Q2 2026, an estimated $234K.
  • Quadrature Capital first reported a position in Cabaletta Bio in Q3 2025 and held it in 3 quarters.
  • Quadrature Capital's Cabaletta Bio position peaked at $234K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.